Antimicrobial Agents and Chemotherapy · 2008 · 13 citations · 16 references
Life SciencesMicrobiologyPharmacologyAntimicrobial PharmacologyAntimicrobial ResistanceMedical MicrobiologyAntibacterial PharmacologyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance MechanismsBacterial Cell StructureCarbapenem ResistanceCarbapenem AntibioticsEscherichia ColiMultidrug-resistant Gram-negative BacteriaNovel Antibacterial Drug DiscoveryPseudomonas Aeruginosa ResistanceResistance Mechanisms In Gram-negative Bacteria
Tomopenem (formerly CS-023), a novel 1beta-methylcarbapenem, exhibited high affinity for penicillin-binding protein (PBP) 2 in Staphylococcus aureus, PBP 2 in Escherichia coli, and PBPs 2 and 3 in Pseudomonas aeruginosa, which are considered major lethal targets. Morphologically, tomopenem induced spherical forms in E. coli and short filamentation with bulges in P. aeruginosa, which correlated with the drug's PBP profiles. The potential of resistance of these bacteria to tomopenem was comparable to that to imipenem.
16